Bioventus (BVS) Change in Receivables (2020 - 2026)

Bioventus (BVS) has reported Change in Receivables for 7 consecutive years, with $17.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables rose 31.64% year-over-year to $17.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (up 204.1% YoY), and the FY2025 full-year result was $916000.0, down 91.41% from the prior year.
• Change in Receivables climbed to $17.9 million in Q2 2026 per BVS's latest filing, from -$7.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $25.6 million in Q3 2022 and bottomed at -$17.1 million in Q3 2024.
• Historically, Change in Receivables has averaged $1.7 million across 5 years, with a median of $4500.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Receivables jumped 989.74% in 2024, then slumped 559.86% in 2025.
• Over 5 years, Change in Receivables stood at $4.8 million in 2022, then surged by 90.23% to $9.2 million in 2023, then sank by 36.99% to $5.8 million in 2024, then plunged by 132.54% to -$1.9 million in 2025, then surged by 1051.78% to $17.9 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $17.9 million, -$7.3 million, and -$1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.